Development and validation of prognostic risk prediction models for hepatocellular carcinoma patients treated with immune checkpoint inhibitors based on a systematic review and meta-analysis of 47 cohorts

OBJECTIVE: To identify the risk factors associated with prognosis in patients with hepatocellular carcinoma (HCC) treated with immune checkpoint inhibitors (ICI) via meta-analysis. And to construct prediction models to aid in the prediction and improvement of prognosis. METHODS: We searched PubMed,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Delin, Liu, Mingkun, Zhai, Xiangyu, Li, Xianzhi, Jin, Bin, Liu, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380940/
https://www.ncbi.nlm.nih.gov/pubmed/37520554
http://dx.doi.org/10.3389/fimmu.2023.1215745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380940/
https://www.ncbi.nlm.nih.gov/pubmed/37520554
http://dx.doi.org/10.3389/fimmu.2023.1215745

Ejemplares similares